Literature DB >> 16278823

Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15.

Kathy King1, Mohammed F Sheikh, Andrew P Cuthbert, Sheila A Fisher, Clive M Onnie, Muddassar M Mirza, Reenal C Pattni, Jeremy Sanderson, Alastair Forbes, John Mansfield, Cathryn M Lewis, Roland G Roberts, Christopher G Mathew.   

Abstract

Three common mutations in the CARD15 (NOD2) gene are known to be associated with susceptibility to Crohn disease (CD), and genetic data suggest a gene dosage model with an increased risk of 2-4-fold in heterozygotes and 20-40-fold in homozygotes. However, the discovery of numerous rare variants of CARD15 indicates that some heterozygotes for the common mutations have a rare mutation on the other CARD15 allele, which would support a recessive model for CD. We addressed this issue by screening CARD15 for mutations in 100 CD patients who were heterozygous for one of the three common mutations. We also developed a strategy for evaluating potential disease susceptibility alleles (DSAs) that involves assessing the degree of evolutionary conservation of involved residues, predicted effects on protein structure and function, and genotyping in a large sample of cases and controls. The evolutionary analysis was aided by sequencing the entire coding region of CARD15 in three primates (chimp, gibbon, and tamarin) and aligning the human sequence with these and orthologs from other species. We found that 11 of the 100 CD patients screened had a second potential pathogenic mutation within the exonic and periexonic sequences examined. Assuming that there are no additional pathogenic mutations in noncoding regions, our study suggests that most carriers of the common DSAs are true heterozygotes, and supports previous evidence for a gene dosage model. Four novel nonsynonymous mutations were detected, one of which would produce premature termination of translation c.2686C>T (p.Arg896X). Two potential DSAs--c.2107C>T (p.Arg703Cys) and g.2238T>A (c.74-7T>A)--were significantly associated with CD in the case control sample. Analysis of the evolution of CARD15 revealed strong conservation of the encoded protein, with identity to the human sequence ranging from 99.1% in the chimp to 44.5% in fugu. Higher primates possess an open reading frame (ORF) upstream of the putative initiation site in other species that encodes a further 27 N-terminal amino acids, while four regions of high conservation are observed outside of the known domains of CARD15, indicative of additional residues of functional importance. The strategy developed here may have general application to the assessment of mutation pathogenicity and genetic models in other complex disorders. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16278823     DOI: 10.1002/humu.20264

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

Review 1.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

2.  Identification of genetic variation and putative regulatory regions in bovine CARD15.

Authors:  Kristen H Taylor; Jeremy F Taylor; Stephen N White; James E Womack
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

3.  Analysis of the NOD2/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease.

Authors:  Marc François Jean André; Olivier Aumaître; Jean-Charles Piette; Gilles Grateau; Marie-Céleste Cardoso; Lemlih Ouchchane; Jean-Louis Kémény; Bernard Dastugue; Marc Delpech; Isabelle Creveaux
Journal:  Dig Dis Sci       Date:  2007-06-15       Impact factor: 3.199

4.  Receptor interacting protein-2 plays a critical role in human lung epithelial cells survival in response to Fas-induced cell-death.

Authors:  Mohd Akhlakur Rahman; Kruthika Sundaram; Srabani Mitra; Mikhail A Gavrilin; Mark D Wewers
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

5.  Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis.

Authors:  Alexander Mentzer; Shalini Nayee; Yasmin Omar; Esther Hullah; Kirstin Taylor; Rishi Goel; Hannah Bye; Tarik Shembesh; Timothy R Elliott; Helen Campbell; Pritash Patel; Anita Nolan; John Mansfield; Stephen Challacombe; Michael Escudier; Christopher G Mathew; Jeremy D Sanderson; Natalie J Prescott
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

6.  Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease.

Authors:  C M Lewis; S C L Whitwell; A Forbes; J Sanderson; C G Mathew; T M Marteau
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

7.  NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.

Authors:  Neema P Mayor; Bronwen E Shaw; J Alejandro Madrigal; Steven G E Marsh
Journal:  Bone Marrow Res       Date:  2012-10-18

8.  Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.

Authors:  Natalie J Prescott; Benjamin Lehne; Kristina Stone; James C Lee; Kirstin Taylor; Jo Knight; Efterpi Papouli; Muddassar M Mirza; Michael A Simpson; Sarah L Spain; Grace Lu; Franca Fraternali; Suzannah J Bumpstead; Emma Gray; Ariella Amar; Hannah Bye; Peter Green; Guy Chung-Faye; Bu'Hussain Hayee; Richard Pollok; Jack Satsangi; Miles Parkes; Jeffrey C Barrett; John C Mansfield; Jeremy Sanderson; Cathryn M Lewis; Michael E Weale; Thomas Schlitt; Christopher G Mathew
Journal:  PLoS Genet       Date:  2015-02-11       Impact factor: 6.020

9.  Valosin-containing protein-regulated endoplasmic reticulum stress causes NOD2-dependent inflammatory responses.

Authors:  Maryam Ghalandary; Yue Li; Thomas Fröhlich; Thomas Magg; Yanshan Liu; Meino Rohlfs; Sebastian Hollizeck; Raffaele Conca; Tobias Schwerd; Holm H Uhlig; Philip Bufler; Sibylle Koletzko; Aleixo M Muise; Scott B Snapper; Fabian Hauck; Christoph Klein; Daniel Kotlarz
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.